FREE ELECTRONIC LIBRARY - Dissertations, online materials

Pages:   || 2 |

«Consumers’ Association’s response to the European Commission’s Discussion paper on nutrition claims and functional claims Introduction ...»

-- [ Page 1 ] --

Consumers’ Association’s response to the European Commission’s

Discussion paper on nutrition claims and functional claims


Consumers’ Association (CA), publisher of Which?, Health Which? and other consumer

magazines and information, is the largest independent consumer organisation in Europe. Food

issues are one of our main campaigning areas and we regularly produce information on food

issues within our publications. At European level, we are members of Bureau Européen des Unions de Consommateurs (BEUC), the European Consumer Organisation. We are also a member of the Trans-atlantic Consumer Dialogue (TACD) and take an active role on the Food Working Group as EU Chair. At international level we are members of Consumers International through which we have representation at Codex Alimentarius.

General comments Our research has shown that consumers currently have very little confidence in the claims made on food. A CA survey last year found that only three in ten people (31 per cent) ‘believe all of the health claims that appear on products nowadays’ and 88 per cent agreed that ‘all health and nutrition claims made on food packaging should be regulated.’ However, an increasing number of foods are making nutrition and health-related claims in response to consumers’ growing interest in health. While we consider that some claims, if carefully controlled, could be useful to consumers and help them to make informed choices and implement dietary advice, others are merely marketing ploys, of little value to consumers and with the potential to mislead.

We therefore welcome this discussion paper as a first step towards EU controls over nutrition and functional claims. However, we do have some concern over the scope of the paper and consider that it should cover all health claims, including disease-risk reduction claims. While from a technical perspective different types of health-related claims can be defined, consumers do not make distinctions between these claims when shopping for food and therefore they should be dealt with together. While different approaches may currently be taken in relation to disease-risk reduction claims across Europe, this is even more reason for them to be dealt with, to ensure that consumers across the EU are provided with the same level of protection. It is important that consumers are not misled either by a direct or implied claim that a food can have medicinal properties and claims must not detract from the importance of eating a varied and balanced diet.

While there is already a general requirement that claims should not mislead consumers, we are concerned that this is inadequate. Where this is found to be the case, enforcement officers can only take action retrospectively and once the product making the claim has already been on the market and consumers have been misled. Many food products are now developed globally and by global companies. Enforcement largely remains the responsibility of local authorities with limited resources. To take action against a claim that is believed to be misleading may therefore often be beyond the resources of some authorities, particularly when it could be considered to be a ‘borderline’ case. A recent case in the UK of Shropshire Trading Standards prosecuting Nestlé over implied claims it made on Shredded Wheat is one of the exceptions where the authority did decide to take action and was successful, but it illustrates the difficulties involved.

It is our view that consumers can only be adequately protected if claims made on foods are vetted and approved before they are used. We are a member of the UK Joint Health Claims Initiative’s Council. This UK body is a tri-partite initiative involving industry, trading standards officers and consumer organisations. It has agreed a Code for the use of claims and has recently appointed an expert committee which will come up with a list of generic claims and then consider innovative claims where dossiers are submitted by industry. We have welcomed this initiative and support it, but are concerned that it is a voluntary approach and therefore many companies will decide not to go down this route. It is also important that controls are harmonised across Europe. It is therefore essential that a mandatory system of prior-approval is established for all health claims. We also consider that the same approach should be taken for nutrition claims: criteria and conditions for their use should be set down in legislation.

Specific comments Definitions Nutrition claims We generally agree with the definition taken from Council Directive 90/496/EEC on nutrition labelling, but do consider that as many claims are now being made about the presence of other substances that are not included in the current definition, it should be extended to ensure that these are included within the scope of the legislation.

Functional claims

It is useful for the sake of consistency to take into account the definitions set down by Codex. It may be useful to make distinctions between different types of claims for technical reasons, but it is important that legislative proposals focus on how consumers perceive health-related claims, rather than making detailed distinctions between different types of claims which will be irrelevant to most people. Focusing on detailed definitions to distinguish between different types of claims can give them a type of legitimacy that is often not appropriate. It should not detract from the main issue of whether or not specific claims can be substantiated and how they should be presented.

We consider that the paper should address all health-related claims, including disease-risk reduction claims, rather than dealing with these at a later date. We agree that claims should not be allowed where they imply that a food has medicinal properties. However many disease-risk reduction claims are being made on products in the UK and elsewhere in Europe and consumers should be able to have confidence that these are not misleading, are made in the context of an overall balanced diet and can be substantiated.

2 We are concerned that at the moment many of the claims that are made, while not strictly making medicinal claims, still give that implication to consumers whether or not they are a medicinal claim according to a strict definition. As part of the research for our Functional Food policy paper, a copy of which is enclosed, we conducted semi-quantitative research which involved half hour interviews with 100 respondents in Sheffield and High Wycombe. Respondents were shown examples of so-called ‘functional foods’ that were on the market at that time and made health claims, together with examples of claims made on other products. The responses showed that although consumers thought that the ‘functional foods’ were foods rather than medicines, they talked about their effects in medical terms. For example, we showed them Benecol spread which claimed to contain ‘a unique ingredient called plant stanol ester which can help to actually lower cholesterol as part of a healthy diet’. After examining the product, over 80 per cent thought that it would help improve a specific health problem. It is unlikely that many consumers would appreciate the difference between a claim made about reducing cholesterol and one made about reducing your risk of heart disease. The reason why someone would be interested in reducing their cholesterol levels would be to reduce their risk of heart disease.

Whatever, the definition of the health claim, it is therefore essential that clear criteria are set which apply to all claims, take into account the likely consumer perception and ensure that consumers realise that the product claim is about maintaining long-term health as part of a healthy diet, rather than assuming that the product is some kind of healthy ‘quick-fix’.

Conditions under which claims can be made It is essential that claims and the products to which they apply fit within the context of an overall healthy diet. Legislation must include implied as well as explicit claims, for example, the use of packaging and promotional material.

Codex’s work on nutrition and health claims provides a useful starting point for Community legislation on nutrition and health-related claims.

The JHCI Code provides useful criteria that could be adopted for the use of health-related claims, including functional claims. The Code can be found at www.jhci.co.uk. Sections 6 and 7 deal with ‘General Principles for Making a Health Claim’ and ‘Labelling and other Consumer Information’.

These in our view include the key provisions summarised below:

• Health claims should assist consumers to make informed choices. Consumers expect that health claims are substantiated and have been checked for accuracy by independent experts prior to use and that they will continue to be controlled by the enforcement authorities.

• The overriding principle is that the likely consumer perception of the claim is paramount. This includes for example the use of marketing imagery, emphasis on certain words, use of pictures, logos, sounds, phrases, shape of packaging or the item itself which may give the impression or implication of a claim, literature provided with the product and the direct, indirect or implied meaning of the claim.

• Health claims must be truthful and must not mislead, exaggerate or deceive either directly or by implication.

• The health claim should be consistent with the nature and scope of the evidence.

–  –  –

• A health claim must not encourage or condone excessive consumption of any food or disparage good dietary practice. The claim will need to be set in the context of the role of the food in relation to the overall diet or other lifestyle factors.

• Health claims should not unfairly denigrate any other food or imply that normal foods cannot provide a healthy diet.

• The benefit from the health claim must be fulfilled by the food consumed as recommended by the company or as directed on the label.

• The benefit from the health claim must be derived wholly from the food (or component) for which the health claim is made and not rely on any benefit derived from consuming the food with other foods even if this might be normal practice or the intended mode of consumption.

• The health claim must be fulfilled in the target population when the food is consumed in the quantities which can reasonably be expected to be consumed in one day or in quantities which make a reasonable contribution to the diet.

• Health claims must be communicated in such a way as to assist consumer understanding of the basis of the health claim such as of the relationship between diets, specific nutrients/components etc and physiological benefits to allow people to make informed and appropriate food choices.

• Vulnerable sectors of the population may have specific nutritional requirements and companies should take care to ensure that health claims do not mislead these sectors.

Likewise, health claims directed at specific sectors of the population should not be presented in such a way as to mislead the general population.

• Health claims which could encourage high levels of consumption must not be made for any substances where there is evidence that high intakes of the food or substance could be harmful or unlikely to contribute to a healthy diet. (See also comments on ‘Nutrition profile’ below).

The following information should also be provided when a health-related claim is made:

full nutrition labelling to include the ‘full 8’ nutrients: energy, protein, carbohydrate, sugar, fat, saturates, fibre and sodium. However, we consider that this information should be compulsory on all pre-packaged foods in any case;

a clear warning if the product contains ingredients unsuitable for certain groups of the population;

a quantified serving size;

the amount of the nutrients/ingredients present to which the claimed benefit relates and how much of the food needs to be eaten to have the desired effect;

–  –  –

a safe maximum intake, where there is the possibility that high intakes could be harmful.

Type of evaluation and authorisation system for claims As stated above, we consider that there should be a system of ‘prior approval’ for nutrition and health-related claims, which include but are not limited to functional claims. Prior approval unfortunately has been taken to mean different things to different people.

Nutrition claims

In relation to nutrition claims, we mean that claims should be assessed beforehand and based on dietary guidelines. They should be defined and clear criteria for their use should be established.

We have welcomed the progress that Codex has made in this area and consider that the criteria that have been established can be incorporated into EU legislation. At the moment, these claims are only covered by voluntary guidelines in the UK. It is essential that they are set down in legislation in order to ensure compliance.

Criteria also need to be established for use of healthy eating logos which are widely used, particularly on supermarket own-label products in the UK. It is not always clear, for example, whether the logo is claiming that the product is an all round ‘healthy’ product or whether it is a healthier alternative to the standard product.

As the discussion paper makes clear, a whole range of terms are now used to make claims, some of which can be confusing for consumers. For this reason they should be defined, and where it is found that they are potentially confusing or misleading, they should not be permitted.

Pages:   || 2 |

Similar works:

«The DE Guide 2012/13 All the information you need from current students! Welcome to ICSM and Clinical Medicine! So you’ve made it through 3 years of lectures, essays, stress, and nervewracking interviews (and you thought that ended with UCAS), and finally you’re ready to be let loose on patients! Everyone looks forward to clinical school, and with good reason, as it’s a chance to get out into hospitals and actually ‘do’ some medicine. ICSM is a great place to be for your next 3 years,...»

«127 PHYSICIAN IN THE SKY STANISLAV JUŽNIč Background (Mathias) Gregor Kraškovič (Kraschovic, Kraskowitz, * March 2, 1767 Studenec in Bloke in today Slovenia; † January 5. 1823 Pile in periphery of Dubrovnik) was one of the best physicians of his era. He pioneered the manned balloon flights and focused his research on the medical circumstances of aeronaut in higher regions of the atmosphere. Kraškovič’s achievements are well known and several web pages are devoted to his work. His...»

«Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Date: April 29, 2010 To: Lisa L. Mathis MD, Associate Director Pediatric and Maternal Health Staff (PMHS) Office of New Drugs (OND), CDER and M. Dianne Murphy, MD, Director Office of Pediatric Therapeutics (OPT), OC Thru: Ann McMahon, MD, MS, Deputy Director or Mark Avigan, MD, CM, Acting Director Lanh Green, PharmD, MPH...»

«Enriching Medical Terminologies: an Approach Based on Aligned Corpora Louise DELEGERa1, Magnus MERKELb, Pierre ZWEIGENBAUMac a INSERM U729, Paris, France b Dept of Computer and Information Science, Linköping University, Sweden c STIM/DSI, Assistance Publique – Hôpitaux de Paris, France Abstract. Medical terminologies such as those in the UMLS are never exhaustive and there is a constant need to enrich them, especially in terms of multilinguality. We present a methodology to acquire new...»

«441 Freedom Parkway NE Atlanta, GA 30307 http://www.jimmycarterlibrary.gov Record Group 220: Cuban-Haitian Task Force: A Guide to Its Records at the Jimmy Carter Library Collection Summary Creator: RG 220: Department of Health and Human Services. Cuban-Haitian Task Force Title: Cuban-Haitian Task Force Dates: 7/15/80-6/1/81 Quantity: 27 linear feet, 7 linear inches, 63 containers Identification: Accession Number: 80-1 National Archives Identifier: 547 Scope and Content: This collection consists...»

«Date: October 31, 2003 From: Karen M. Farizo, M.D. Medical Officer Vaccines Clinical Trials Branch Division of Vaccines and Related Product Applications Office of Vaccines Research and Review Center for Biologics Evaluation and Research Food and Drug Administration Subject: Clinical Review of New Product License Application for Tetanus and Diphtheria Toxoids Adsorbed For Adult Use, manufactured by Aventis Pasteur Limited To: BLA STN# 103171 Through: Antonia Geber, M.D. Chief, Vaccines Clinical...»

«Distribution Agreement In presenting this thesis or dissertation as a partial fulfillment of the requirements for an advanced degree from Emory University, I hereby grant to Emory University and its agents the non-exclusive license to archive, make accessible, and display my thesis or dissertation in whole or in part in all forms of media, now or hereafter known, including display on the world wide web. I understand that I may select some access restrictions as part of the online submission of...»

«BMJ LEARNING PODCAST TRANSCRIPT MISCARRIAGE MANAGEMENT IN PRIMARY CARE File: Miscarriage FINAL.mp3 Duration: 0:29:50 Date: 06/02/2013 Typist: CR6 START AUDIO You’re listening to an audio module from BMJ Learning.Male: Charles: Hello. I'm Dr. Charles Hall, a Clinical Editor at BMJ Learning. In this module we discuss the management of miscarriage in primary care. Here to talk to us is Dr. Nicola Davis, a GP in Luton, Medical Trainer, and a trustee of The Miscarriage Association. Hello Nicola....»

«Ministry of Health Sri Lanka National Guidelines Guidelines on Management of Dengue Fever & Dengue Haemorrhagic Fever In Adults In Collaboration with the Ceylon College of Physicians Revised and expanded edition November 2012 The guidelines, published in November 2012, supersede the previous guidelines on Management of Dengue Fever / Dengue Haemorrhagic Fever published by the Epidemiology Unit, Ministry of Health in 2010. These guidelines were developed based on the best available evidence at...»

«GRADUATE PROGRAM STUDENT HANDBOOK 2015-16 WELCOME TO THE DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY Biochemistry and Molecular Biology are sciences at the epicenter of modern biomedical research. Understanding basic biochemical pathways is key to gaining new knowledge for the prevention and combating of disease, allowing for the expansion of current boundaries in medicine and science. In addition to medical applications, molecular biology is indispensable for the development of tools...»

«Tips and Tools for Single Parents Flying Solo – Parenting Alone – Sheryl Giesbrecht October 17, 2009, I became a single parent. My husband of 28 years, Pastor Paul Giesbrecht, was killed in a tragic motor-cycle accident. From the day he died, I made major decisions – about housing, income, vehicles, college funding, health insurance, life insurance. A decision I dreaded was how to love my children as a solo parent – how could I parent alone? Single Parent – It’s almost like a curse...»

«Glaucoma What You Should Know U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute The National Eye Institute (NEI) conducts and supports research that leads to sight-saving treatments and plays a key role in reducing visual impairment and blindness. NEI is part of the National Institutes of Health, an agency of the U.S. Department of Health and Human Services. For more information, contact— National Eye Institute National Institutes of Health 2020...»

<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.